• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

PET/CT is a cost-effective tool against cancer: synergy supersedes singularity.

作者信息

Fischer Barbara Malene, Siegel Barry A, Weber Wolfgang A, von Bremen Konrade, Beyer Thomas, Kalemis Antonis

机构信息

Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Division of Nuclear Medicine, Mallinckrodt Institute of Radiology and Alvin J. Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO, USA.

出版信息

Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1749-52. doi: 10.1007/s00259-016-3414-5. Epub 2016 May 13.

DOI:10.1007/s00259-016-3414-5
PMID:27178271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4969342/
Abstract
摘要

相似文献

1
PET/CT is a cost-effective tool against cancer: synergy supersedes singularity.正电子发射断层显像/计算机断层扫描（PET/CT）是对抗癌症的一种性价比高的工具：协同作用胜过单一作用。
Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1749-52. doi: 10.1007/s00259-016-3414-5. Epub 2016 May 13.
2
Cost-effectiveness of PET and PET/computed tomography: a systematic review.正电子发射断层扫描（PET）及PET/计算机断层扫描的成本效益：一项系统评价
PET Clin. 2015 Jan;10(1):105-24. doi: 10.1016/j.cpet.2014.09.008. Epub 2014 Oct 14.
3
Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [18F]fluorodeoxyglucose PET and CT comparison.已知或疑似肺癌患者临床管理中的成本效益分析：[18F]氟脱氧葡萄糖PET与CT对比
Q J Nucl Med Mol Imaging. 2007 Sep;51(3):224-34. Epub 2007 Jun 1.
4
Is FDG PET/CT cost-effective for pre-operation staging of potentially operative non-small cell lung cancer? - From Chinese healthcare system perspective.18F-FDG PET/CT 用于潜在可手术的非小细胞肺癌术前分期的成本效益如何？——基于中国医疗体系视角。
Eur J Radiol. 2012 Aug;81(8):e903-9. doi: 10.1016/j.ejrad.2012.05.006. Epub 2012 Jun 13.
5
Focus on Radionuclide Imaging and PET CT: Commentary.聚焦放射性核素成像与正电子发射断层显像计算机断层扫描：述评
Clin Radiol. 2016 Jul;71(7):619. doi: 10.1016/j.crad.2016.03.003. Epub 2016 Apr 16.
6
Saving costs in cancer patient management through molecular imaging.通过分子成像降低癌症患者管理成本。
Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2153-2157. doi: 10.1007/s00259-017-3804-3. Epub 2017 Aug 14.
7
Contribution of imaging to cancer care costs.影像学在癌症治疗费用中的作用。
J Nucl Med. 2011 Dec;52 Suppl 2:86S-92S. doi: 10.2967/jnumed.110.085621.
8
The cost-utility analysis of 18-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of recurrent nasopharyngeal carcinoma.18-氟-2-脱氧葡萄糖正电子发射断层扫描在复发性鼻咽癌诊断中的成本效用分析
Acad Radiol. 2009 Jan;16(1):54-60. doi: 10.1016/j.acra.2008.06.012.
9
Inpatient FDG PET/CT: Point-A Strategic Path to Patient-Centered Yet Cost-Effective Care.住院患者氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描（FDG PET/CT）：以患者为中心且具成本效益的医疗护理的关键战略路径。
AJR Am J Roentgenol. 2024 Jul;223(1):e2330585. doi: 10.2214/AJR.23.30585. Epub 2024 Jan 10.
10
[Positron emission tomography and the Hungarian PET program].[正电子发射断层扫描与匈牙利正电子发射断层扫描项目]
Orv Hetil. 2002 May 26;143(21 Suppl 3):1235-40.

引用本文的文献

1
[F]FDG PET/CT performs better than CT in determining the bone biopsy site : randomized controlled clinical trial.FDG PET/CT 比 CT 更能准确确定骨活检部位：一项随机对照临床试验。
Cancer Imaging. 2024 Nov 24;24(1):160. doi: 10.1186/s40644-024-00804-6.
2
Development and first-in-human study of PSMA-targeted PET tracers with improved pharmacokinetic properties.PSMA 靶向 PET 示踪剂的开发及人体首秀：改善药代动力学特性。
Eur J Nucl Med Mol Imaging. 2024 Jul;51(9):2819-2832. doi: 10.1007/s00259-024-06726-6. Epub 2024 Apr 29.
3
18F-fluoro-2-deoxy-2-d-glucose PET-CT (FDG PET-CT) in staging of high-risk renal and urothelial bladder cancers (COPPER-T) trial protocol.18F-氟-2-脱氧-2-D-葡萄糖PET-CT（FDG PET-CT）用于高危肾癌和尿路上皮膀胱癌分期（COPPER-T）试验方案。
BJUI Compass. 2023 May 10;4(6):662-667. doi: 10.1002/bco2.246. eCollection 2023 Nov.
4
Cost-effectiveness of 2-[F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study.2-[F]FDG-PET/CT 与 CE-CT 用于转移性乳腺癌患者疗效监测的成本效益比较：基于登记的对照研究。
Sci Rep. 2023 Sep 28;13(1):16315. doi: 10.1038/s41598-023-43446-7.
5
The Role of F-FDG PET/CT in the Management of the Autoimmune Thyroid Diseases.F-FDG PET/CT在自身免疫性甲状腺疾病管理中的作用
Front Endocrinol (Lausanne). 2019 Apr 5;10:208. doi: 10.3389/fendo.2019.00208. eCollection 2019.
6
PET/CT and brain MRI role in staging NSCLC: prospective assessment of the accuracy, reliability and cost-effectiveness.PET/CT与脑部MRI在非小细胞肺癌分期中的作用：对准确性、可靠性及成本效益的前瞻性评估
Lung Cancer Manag. 2018 May 31;7(2):LMT02. doi: 10.2217/lmt-2018-0008. eCollection 2018 Jun.
7
Paediatric gliomas: diagnosis, molecular biology and management.小儿胶质瘤：诊断、分子生物学与治疗
Ann Transl Med. 2018 Jun;6(12):251. doi: 10.21037/atm.2018.05.11.
8
Screening and Biosensor-Based Approaches for Lung Cancer Detection.基于筛查和生物传感器的肺癌检测方法。
Sensors (Basel). 2017 Oct 23;17(10):2420. doi: 10.3390/s17102420.
9
Predictive medicine: towards a multi-parametric imaging for a personal risk stratification.预测医学：迈向用于个人风险分层的多参数成像。
Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):196-198. doi: 10.1007/s00259-016-3522-2.

本文引用的文献

1
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.PET-CT 监测与颈部清扫术在头颈部晚期癌症中的应用。
N Engl J Med. 2016 Apr 14;374(15):1444-54. doi: 10.1056/NEJMoa1514493. Epub 2016 Mar 23.
2
PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status.用于前列腺癌放射性核素成像与治疗的PSMA配体：临床现状
Theranostics. 2015 Oct 18;5(12):1388-401. doi: 10.7150/thno.13348. eCollection 2015.
3
Imaging-Based Treatment Adaptation in Radiation Oncology.基于影像学的放射肿瘤治疗调整。
J Nucl Med. 2015 Dec;56(12):1922-9. doi: 10.2967/jnumed.115.162529. Epub 2015 Oct 1.
4
The $2.6 billion pill--methodologic and policy considerations.价值26亿美元的药物——方法学与政策考量
N Engl J Med. 2015 May 14;372(20):1877-9. doi: 10.1056/NEJMp1500848.
5
Imaging tumour hypoxia with positron emission tomography.利用正电子发射断层扫描成像技术检测肿瘤缺氧情况。
Br J Cancer. 2015 Jan 20;112(2):238-50. doi: 10.1038/bjc.2014.610. Epub 2014 Dec 16.
6
Redistribution of health care costs after the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2005.1998 年至 2005 年间，医疗保险受益人群中非小细胞肺癌患者采用正电子发射断层扫描技术后医疗费用的再分配。
J Thorac Oncol. 2014 Apr;9(4):512-8. doi: 10.1097/JTO.0000000000000102.
7
Appraising iniparib, the PARP inhibitor that never was--what must we learn?评估伊匹单抗，从未上市的 PARP 抑制剂——我们必须吸取哪些教训？
Nat Rev Clin Oncol. 2013 Dec;10(12):688-96. doi: 10.1038/nrclinonc.2013.177. Epub 2013 Oct 15.
8
Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results.18F-FACBC 和 11C-胆碱 PET/CT 在根治性治疗后生化复发的前列腺癌患者中的比较：初步结果。
Eur J Nucl Med Mol Imaging. 2013 Jul;40 Suppl 1:S11-7. doi: 10.1007/s00259-013-2373-3. Epub 2013 Apr 17.
9
PET imaging in prostate cancer: focus on prostate-specific membrane antigen.前列腺癌的 PET 成像：关注前列腺特异性膜抗原。
Curr Top Med Chem. 2013;13(8):951-62. doi: 10.2174/1568026611313080008.
10
Generating evidence for clinical benefit of PET/CT in diagnosing cancer patients.为 PET/CT 在癌症患者诊断中的临床获益提供证据。
J Nucl Med. 2011 Dec;52 Suppl 2:77S-85S. doi: 10.2967/jnumed.110.085704.